Related Experiment Video

Updated: Jul 24, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

[HGV and TTV - new hepatitis viruses]

A S Loginov, T I Sharafanova, V I Reshetniak

    Terapevticheskii Arkhiv
    |March 29, 2001
    PubMed

    Insights

    Hepatitis G virus (HGV) and TT virus (TTV) infections were found in nearly 20% and 12% of chronic liver disease patients, respectively. Their exact role in liver disease and treatment efficacy require further investigation.

    Area of Science:

    • Hepatology
    • Virology
    • Immunology

    Background:

    • Chronic hepatic diseases (CHD) present complex etiological challenges.
    • Hepatitis G virus (HGV) and TT virus (TTV) are emerging viral agents with incompletely understood roles in liver pathology.

    Purpose of the Study:

    • To investigate the clinical, immunological, and morphological characteristics of HGV and TTV infections in patients with CHD.
    • To evaluate the effectiveness of interferon-alpha treatment in HGV-seropositive patients, particularly those with co-infections.

    Main Methods:

    • Analysis of 202 patients with CHD for markers of HBV, HCV, HGV, and TTV infections.
    • Liver biopsy was performed on a subset of patients.
    • Interferon-alpha treatment efficacy was assessed in patients with HGV and HBV/HCV co-infections.

    Main Results:

    • HGV RNA and TTV DNA were detected in 19.8% and 11.8% of patients, respectively.
    • Biochemical and morphological changes in patients with HGV and TTV monoinfections indicated a potential role in liver disease.
    • Two out of seven patients with HGV + HBV/HCV co-infections showed a positive response to interferon-alpha treatment after 3 months.

    Conclusions:

    • The precise contribution of HGV and TTV to the pathogenesis of chronic hepatic diseases remains uncertain.
    • Further research is essential for the detection and comprehensive examination of patients infected with HGV and TTV.
    • Therapeutic strategies should consider the presence of HGV RNA, TTV DNA, viral genome in hepatocytes, and histological liver changes.
    Abstract

    More Related Videos

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers07:58

    Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers

    Published on: May 22, 2026

    Related Concept Videos

    Viral Recombination00:57

    Viral Recombination

    Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
    Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

    Transmission-based Precautions I: Contact, Enteric, and Droplets

    Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
    Contact Precautions:
    Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Genital Herpes01:23

    Genital Herpes

    Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
    Inhibitors of Virion Maturation and Assembly01:19

    Inhibitors of Virion Maturation and Assembly

    As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...